IL6R and thromboangiitis obliterans: The left eyeballs of the mice in the different experimental groups saw visible changes in the treated groups compared to the healthy controls, with the (anti-mmu-IL-6R), (anti-mmu-IL-6R)-MS, and (anti-mmu-IL-6R)-MS-CD34 Apt groups showing a reduction in ocular inflammation compared to TAO mice (Fig. 8A).